1998•PubMedRequires access

[A case of advanced hepatocellular carcinoma responding to suppository of Tegafur].

Kyousuke Kudo, Ayumu Arakawa, Yaeko TAKAGI, Rimei Nishimura, Yoshiaki Yamashita, Mina Takahashi

Abstract

We report a case of advanced hepatocellular carcinoma (HCC) successfully controlled by the suppository administration of Tegafur alone. Five months after initiation of the drug, excellent reduction of tumors and decrease of serum alpha-feto-protein (AFP) level were seen without any side effects. Also, twenty-four months after of the treatment, no regrowth of tumors or increase in the serum AFP level was seen. Because Tegafur is a time-dependent agent, advanced HCC may be controlled by continuous administration for a long period.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Tegafur, Suppository, Hepatocellular carcinoma, Medicine, Internal medicine, Gastroenterology, Oncology, Pharmacology